HAI Diagnostic and Testing Markets Show 3 Percent Growth
A new market research report from Kalorama Information, "Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends," says that diagnostics and treatment segments taken together are valued at more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion.
The market has grown by 3 percent year-on-year, with sales increasing from $7.9 billion in 2005. With the treatment segment struggling to maintain growth, the testing segment is likely to offset declines starting in 2012.
Uncovering a Hidden Risk: Alcohol Use Disorder Significantly Increases C difficile Infection Rates
April 10th 2025A groundbreaking study reveals a strong connection between alcohol use disorder and increased risk for Clostridioides difficile infection, challenging traditional assumptions and calling for enhanced infection prevention protocols.
